Clinical Trial

Correcting Hypocapnia in Aneurysmal Subarachnoid Hemorrhage.

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Based on the clinical observation that over half of the patients in the management of aneurysmal subarachnoid hemorrhage(aSAH) present with spontaneous hyperventilation, which is significantly associated with delayed cerebral ischemia and poor neurological outcomes, this prospective pilot study is designed to investigate the safety and efficacy of normobaric facemask oxygen for hypocapnia in aSAH.
Trial Details
NCT Number NCT07343232
Lead Sponsor The Chinese University of Hong Kong, Shenzhen
Conditions Aneurysmal Subarachnoid Hemorrhage (aSAH)
Enrollment 80 participants
Start Date 2026-01-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-15